用MSCs-exosomes丰富的基托桑-PEG水凝进行体外评估,以促进伤口愈合
Masoumeh Ezati1, Amir Hashemi1, Inna Zumberg1
1Department of Biomedical Engineering, Faculty of Electrical Engineering and Communication, Brno University of Technology, Technicka 3082/12, Brno, 61600, Czech Republic.
Macromolecular bioscience
|January 22, 2025
概括
这项研究开发了一种新型的水凝伤口敷料,载有介质干细胞衍生的外生体 (MSCs-Exos),以加速皮肤再生. 先进的带促进更快的愈合,减少痕,为复杂的伤口提供了一个有希望的解决方案.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 组织工程是组织工程.
背景情况:
- 皮肤组织再生具有挑战性,特别是对于糖尿病患者来说,往往导致痕和延迟愈合.
- 有药物输送系统的治疗带正在出现,以解决这些伤口并发症.
- 介质细胞干细胞衍生外体 (MSCs-Exos) 提供无细胞的治疗效益,包括抗炎和组织修复特性.
研究的目的:
- 开发和评估一种先进的伤口包裹,将奇托 (CS) 和聚乙烯糖醇 (PEG) 水凝与脂肪MSCs衍生的Exos (ADMSCs-Exos) 结合起来.
- 评估这种复合水凝-外体在促进严重皮肤损伤愈合方面的有效性.
- 为了调查体外机制的基础上增强的伤口愈合特性.
主要方法:
- 使用简单的混合技术制造装载ADMSCs-Exos的CS-PEG水凝.
- 在体外评估内皮细胞迁移,氧化应激减轻和血管生成.
- 实时聚合酶连锁反应 (RT-PCR) 分析,以评估与伤口愈合相关的基因表达.
主要成果:
- 液凝外体显著增强了内皮细胞迁移.
- 这种敷料在体外有效降低了氧化应激标志物.
- 促进了血管新生,并通过RT-PCR显示了关键伤口愈合基因的显著上调.
结论:
- 开发的水凝外体复合带显示了改善严重皮肤损伤愈合的巨大潜力.
- 这种创新的包裹为先进的伤口护理提供了一个有前途的无细胞治疗策略.
- 水凝和外体的组合促进了持续释放和协同治疗效果.
相关概念视频
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


